SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009369
Filing Date
2017-05-08
Accepted
2017-05-08 16:01:34
Documents
47
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q snss-10q_20170331.htm 10-Q 1044592
2 EX-10.2 snss-ex102_559.htm EX-10.2 18084
3 EX-31.1 snss-ex311_560.htm EX-31.1 16362
4 EX-31.2 snss-ex312_561.htm EX-31.2 16312
5 EX-32.1 snss-ex321_562.htm EX-32.1 6416
6 GRAPHIC g201705070631049605107.jpg GRAPHIC 3336
  Complete submission text file 0001564590-17-009369.txt   3661121

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snss-20170331.xml EX-101.INS 697040
8 XBRL TAXONOMY EXTENSION SCHEMA snss-20170331.xsd EX-101.SCH 34449
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20170331_cal.xml EX-101.CAL 36863
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20170331_def.xml EX-101.DEF 85890
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20170331_lab.xml EX-101.LAB 243441
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20170331_pre.xml EX-101.PRE 163799
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 17822170
SIC: 2834 Pharmaceutical Preparations